Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-13 3:33 pm Sale | 2022-12-31 | 13G | HTG MOLECULAR DIAGNOSTICS INC HTGM | LYTTON LAURENCE W | 0 0.000% | -43,474 (Position Closed) | Filing History |
| 2023-02-10 09:03 am Sale | 2022-12-31 | 13G | HTG MOLECULAR DIAGNOSTICS INC HTGM | Samjo Capital LLC | 0 0.000% | -51,258 (Position Closed) | Filing History |
| 2023-02-03 4:02 pm Unchanged | 2022-12-31 | 13G | HTG MOLECULAR DIAGNOSTICS INC HTGM | Cowen Prime Advisors LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2022-12-07 06:01 am Sale | 2022-12-06 | 13D | HTG MOLECULAR DIAGNOSTICS INC HTGM | Hyperscale Data, Inc. GPUS | 39,167 4.250% | -27,500 (-41.25%) | Filing History |
| 2022-12-02 4:30 pm Sale | 2022-11-30 | 13D | HTG MOLECULAR DIAGNOSTICS INC HTGM | Hyperscale Data, Inc. GPUS | 66,667 7.240% | -25,000 (-27.27%) | Filing History |
| 2022-08-05 06:01 am Purchase | 2022-07-26 | 13D | HTG MOLECULAR DIAGNOSTICS INC HTGM | Hyperscale Data, Inc. GPUS | 91,667 9.960% | 91,667 (New Position) | Filing History |
| 2022-07-28 1:06 pm Sale | 2022-07-28 | 13G | HTG MOLECULAR DIAGNOSTICS INC HTGM | The Hewlett Fund LP | 2,083 0.226% | -41,574 (-95.23%) | Filing History |
| 2022-07-18 09:00 am Purchase | 2022-07-18 | 13G | HTG MOLECULAR DIAGNOSTICS INC HTGM | L5 Capital Inc. | 97,500 10.590% | 47,500 (+95.00%) | Filing History |
| 2022-06-29 09:00 am Purchase | 2022-06-28 | 13G | HTG MOLECULAR DIAGNOSTICS INC HTGM | L5 Capital Inc. | 50,000 5.400% | 50,000 (New Position) | Filing History |
| 2022-03-31 4:05 pm Sale | 2022-03-21 | 13G | HTG MOLECULAR DIAGNOSTICS INC HTGM | Orin Hirschman | 0 0.000% | -51,167 (Position Closed) | Filing History |
| 2022-02-15 2:16 pm Purchase | 2021-12-31 | 13G | HTG MOLECULAR DIAGNOSTICS INC HTGM | LYTTON LAURENCE W | 43,474 6.800% | 3,106 (+7.69%) | Filing History |
| 2022-02-14 08:15 am Sale | 2021-12-31 | 13G | HTG MOLECULAR DIAGNOSTICS INC HTGM | Nantahala Capital Management, LLC | 27,918 4.400% | -2,384 (-7.87%) | Filing History |
| 2022-02-11 3:36 pm Purchase | 2021-12-31 | 13G | HTG MOLECULAR DIAGNOSTICS INC HTGM | Orin Hirschman | 51,167 11.000% | 167 (+0.33%) | Filing History |
| 2022-02-09 12:34 pm Purchase | 2021-12-31 | 13G | HTG MOLECULAR DIAGNOSTICS INC HTGM | Cowen Prime Advisors LLC | 49,428 8.000% | 49,428 (New Position) | Filing History |
| 2022-02-08 1:57 pm Purchase | 2021-12-31 | 13G | HTG MOLECULAR DIAGNOSTICS INC HTGM | Samjo Capital LLC | 51,258 8.100% | 18,782 (+57.83%) | Filing History |
| 2022-01-04 11:30 am Purchase | 2021-12-31 | 13G | HTG MOLECULAR DIAGNOSTICS INC HTGM | The Hewlett Fund LP | 43,657 6.923% | 9,583 (+28.12%) | Filing History |